We report a case of intravenous catheter-associated fungemia caused by Candida rugosa; this is the first report of such an infection in a human. Multiple cultures of blood taken over a 24-h period and of the intravenous catheter tip were positive for this unusual isolate. 
Fungemia is an infection that is usually nosocomial and that often develops in the setting of antimicrobial therapy, cancer chemotherapy, bowel surgery, or the use of intravenous plastic catheters. The majority of isolates are Candida spp., particularly Candida albicans and C. tropicalis (1, 4, 5, 9) ; although C. rugosa has been isolated from humans on rare occasions (2, 8) (12) . It has subsequently been isolated from bovine droppings, stale butter, a margarine factory, and seawater (12) . In a study of bovine mastitis in New York and Iowa, C. rugosa was the second most frequently isolated yeast (10) . The however, and to our knowledge it has never been reported to cause fungemia in humans. The source of infection in our patient was obscure.
Our isolates of C. rugosa were accurately identified initially by the API 20C yeast identification system and then confirmed by the Wickerham assimilation and fermentation procedures at the Centers for Disease Control. Our isolates of C. rugosa were susceptible to all three antimycotic agents evaluated; in a study of the in vitro susceptibility of 18 species of yeasts isolated from infected bovine mammary glands, however, C. rugosa was the least susceptible of all the species evaluated (10). None of 13 C. rugosa isolates was susceptible to a 9.6-,ug amphotericin B disk or to a 45-,ug 5-fluorocytosine disk, and only 23% were inhibited by a 4.8-,ug miconazole disk; 100% were inhibited by a 1.0-,ug ketaconazole disk (7) .
In summary, C. rugosa should be added to the list of opportunistic pathogens that may be associated with intravascular-device infections.
